• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Dex Media

Dex Media

  1. All
  2. 3rd Party
  1. Acetylon Presents Early Phase 1a/1b Results for Citarinostat (ACY-241) in Combination with Pomalyst® and Dexamethasone Showing Promising Treatment Responses in Relapsed or Relapsed-and-Refractory ...

    Acetylon Presents Early Phase 1a/1b Results for Citarinostat (ACY-241) in Combination with Pomalyst® and Dexamethasone Showing Promising Treatment Responses in Relapsed or Relapsed-and-Refractory Multiple Myeloma

  2. Nearly 350 Abstracts Evaluating Celgene Therapies to Be Presented at American Society of Hematology Annual Meeting (ASH)

    Nearly 350 Abstracts Evaluating Celgene Therapies to Be Presented at American Society of Hematology Annual Meeting (ASH)

  3. 6 Must-Knows About Strategic Beta Funds

    What they are, where they came from, where they're going--and how to evaluate them. 

  4. Nearing the End of a Decent Year in CEFs

    Falling oil prices buffet some CEFs, but many have turned out strong returns so far this year.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.